metastatic
Financial and Psychosocial Challenges Among Women with Metastatic Breast Cancer: A Qualitative Study
Background:
The cost of cancer treatment is higher for breast cancer than any other cancer diagnosis, leaving women with metastatic breast cancer ...
Effectiveness of Biologic Agents Among Hispanic Patients With Metastatic Colorectal Cancer
Background:
Randomized clinical trials have defined the survival advantage with the addition of biologic drugs to chemotherapy in pa...
Study Results Indicate Palliative Care Less Common Among Racial Minority Patients With Metastatic Breast Cancer
Non-Hispanic Black, Hispanic, Asian or Pacific Islander patients with metastatic breast cancer were found to be less likely to receive palliative c...
Impact of socioeconomic status and rurality on cancer-specific survival among women with de novo metastatic breast cancer by race/ethnicity
Purpose:
There are approximately 150,000 women living with metastatic breast cancer (mBC) in the United States. Disparities in de no...
Dr Hatem Soliman on Disparities in Metastatic Breast Cancer
Hatem Soliman, MD, medical director of the Clinical Trials Office, Moffitt Cancer Center, discusses his presentation at the National Association of...
Survival Benefit of Chemotherapy for Metastatic Prostate Cancer Differs by Race
Chemotherapy for metastatic prostate cancer may not offer the same survival benefit across different race/ethnicity groups, according to findings p...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
